P253 Economic impact of 21-gene recurrence score testing on early stage breast cancer in Ireland

The Breast ◽  
2015 ◽  
Vol 24 ◽  
pp. S113 ◽  
Author(s):  
L. Smyth ◽  
G. Watson ◽  
C.M. Kelly ◽  
M. Keane ◽  
M.J. Kennedy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Economic Impact ◽  
Early Stage ◽  
Recurrence Score ◽  
Early Stage Breast Cancer

Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland

2015 ◽  
Vol 153 (3) ◽  
pp. 573-582 ◽  
Author(s):  
Lillian Smyth ◽  
Geoff Watson ◽  
Elaine M. Walsh ◽  
Catherine M. Kelly ◽  
Maccon Keane ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Economic Impact ◽  
Early Stage ◽  
Recurrence Score ◽  
Early Stage Breast Cancer

scholarly journals Combined pathologic‐genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay

2018 ◽  
Vol 29 (5) ◽  
pp. 1280-1285 ◽  
Author(s):  
M.M. Gage ◽  
W.C. Mylander ◽  
M. Rosman ◽  
T. Fujii ◽  
F. Le Du ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Stage ◽  
Recurrence Score ◽  
Cost Effective ◽  
Early Stage Breast Cancer ◽  
Effective Use
Sign in / Sign up

Export Citation Format

Share Document